Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guidelines: a European Renal Best Practice (ERBP) commentary statement

被引:77
作者
Goldsmith, David J. A. [1 ]
Covic, Adrian [2 ]
Fouque, Denis [3 ,4 ]
Locatelli, Francesco [5 ]
Olgaard, Klaus [6 ]
Rodriguez, Mariano [7 ]
Spasovski, Goce [8 ]
Urena, Pablo [9 ,10 ,11 ]
Zoccali, Carmine [12 ,13 ]
London, Gerard Michel [14 ]
Vanholder, Raymond [15 ]
机构
[1] Kings Hlth Partners, London SE1 9RT, England
[2] Univ Med Gr T Popa, CI Parhon Univ Hosp, Iasi, Romania
[3] Univ Lyon 1, Div Nephrol, Hop Edouard Herriot, F-69365 Lyon, France
[4] Univ Lyon 1, INSERM, U870, F-69365 Lyon, France
[5] A Manzoni Hosp, Dept Nephrol Dialysis & Transplantat, Lecce, Italy
[6] Univ Copenhagen, Rigshosp, Dept Nephrol P2132, DK-2100 Copenhagen, Denmark
[7] Hosp Univ Reina Sofia, Serv Nefrol Redinren, Unidad Invest, Cordoba, Spain
[8] Univ Skopje, Fac Med, Dept Nephrol, Skopje, Macedonia
[9] Hop Necker Enfants Malad, Serv Explorat Fonct, Paris, France
[10] Serv Nephrol & Dialyse, Clin Landy, St Ouen, France
[11] Univ Paris 05, Ctr Rech Croissance & Signalisat, Paris, France
[12] Osped Riuniti Reggio Calabria, CNR IBIM, Reggio Di Calabria, Italy
[13] Osped Riuniti Reggio Calabria, Unita Operat Nefrol Dialisi & Trapianto, Reggio Di Calabria, Italy
[14] INSERM, U970, Paris, France
[15] Ghent Univ Hosp, Dept Internal Med, Nephrol Sect, B-9000 Ghent, Belgium
关键词
calcium; chronic kidney disease mineral and bone disorder; colecalciferol; phosphate; vitamin D; CLINICAL-PRACTICE GUIDELINES; VITAMIN-D; POSITION STATEMENT; VASCULAR CALCIFICATION; CARDIOVASCULAR EVENTS; DIALYSIS OUTCOMES; PRACTICE PATTERNS; METABOLISM; HEMODIALYSIS; OSTEODYSTROPHY;
D O I
10.1093/ndt/gfq513
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Under the auspices of the European Renal Best Practice, a group of European nephrologists, not serving on the Kidney Disease Improving Global Outcomes (KDIGO) working group, but with significant clinical and research interests and expertise in these areas, was invited to examine and critique the Chronic Kidney Disease-Mineral and Bone Disorder KDIGO document published in August 2009. The final form of this paper in Nephrology Dialysis Transplantation, as a commentary, not as a position statement, reflects the fact that we have had no more evidence to review, discuss and debate available to us than was available to the KDIGO working group. However, we have felt that we were able to comment on specific areas where we feel that further clinical guidance would be helpful, thereby going beyond the KDIGO position as reflected in their document. This present paper, we hope, will be of most use to the practising kidney specialist and those allied to the clinical team.
引用
收藏
页码:3823 / 3831
页数:10
相关论文
共 39 条
[1]   Femoral bone mineral density reflects histologically determined cortical bone volume in hemodialysis patients [J].
Adragao, T. ;
Herberth, J. ;
Monier-Faugere, M. -C. ;
Branscum, A. J. ;
Ferreira, A. ;
Frazao, J. M. ;
Malluche, H. H. .
OSTEOPOROSIS INTERNATIONAL, 2010, 21 (04) :619-625
[2]   Bisphosphonate Use in Chronic Kidney Disease: Association with Adynamic Bone Disease in a Bone Histology Series [J].
Amerling, Richard ;
Harbord, Nikolas B. ;
Pullman, James ;
Feinfeld, Donald A. .
BLOOD PURIFICATION, 2010, 29 (03) :293-299
[3]  
BIGGAR PH, 2010, PEDIAT NEPH IN PRESS
[4]   A randomized double-blind pilot study of serum phosphorus normalization in chronic kidney disease: A new paradigm for clinical outcomes studies in nephrology [J].
Block, Geoffrey A. ;
Persky, Martha S. ;
Ketteler, Markus ;
Kestenbaum, Bryan ;
Thadhani, Ravi ;
Kooienga, Laura ;
Spiegel, David ;
Asplin, John ;
Ehrlich, James ;
Dennis, Vincent ;
Nissenson, Allen ;
Chertow, Glenn M. ;
Wheeler, David C. .
HEMODIALYSIS INTERNATIONAL, 2009, 13 (03) :360-362
[5]   The Effects of Vitamin D Therapy on Left Ventricular Structure and Function - Are These the Underlying Explanations for Improved CKD Patient Survival? [J].
Covic, Adrian ;
Voroneanu, Luminita ;
Goldsmith, David .
NEPHRON CLINICAL PRACTICE, 2010, 116 (03) :C187-C195
[6]   Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) hepatitis C guidelines: a European Renal Best Practice (ERBP) position statement [J].
Covic, Adrian ;
Abramowicz, Daniel ;
Bruchfeld, Annette ;
Leroux-Roels, Geert ;
Samuel, Didier ;
van Biesen, Wim ;
Zoccali, Carmine ;
Zoulim, Fabien ;
Vanholder, Raymond .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (03) :719-727
[7]   Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease [J].
Covic, Adrian ;
Kothawala, Prajesh ;
Bernal, Myriam ;
Robbins, Sean ;
Chalian, Arpi ;
Goldsmith, David .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (05) :1506-1523
[8]   Implementation of 'K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease' after the introduction of cinacalcet in a population of patients on chronic haemodialysis [J].
Dolores Arenas, Maria ;
Alvarez-Ude, Fernando ;
Teresa Gil, Maria ;
Moledous, Analia ;
Malek, Tamara ;
Nunez, Carlos ;
Devesa, Ramon ;
Antonia Carreton, Maria ;
Soriano, Antonio .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (06) :1639-1644
[9]   Treatment of Secondary Hyperparathyroidism in CKD Patients with Cinacalcet and/or Vitamin D Derivatives [J].
Drueeke, Tilman B. ;
Ritz, Eberhard .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 4 (01) :234-241
[10]   On the evolving nature of understanding dialysis-related disorders [J].
Eknoyan, G ;
Lindberg, JS .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (04) :S1-S3